Administration, Intravesical: The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms.Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER.Urinary Bladder: A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION.BCG Vaccine: An active immunizing agent and a viable avirulent attenuated strain of Mycobacterium tuberculosis, var. bovis, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity.Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.Cystitis: Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.Cystoscopy: Endoscopic examination, therapy or surgery of the urinary bladder.Urinary Bladder Diseases: Pathological processes of the URINARY BLADDER.Cystitis, Interstitial: A condition with recurring discomfort or pain in the URINARY BLADDER and the surrounding pelvic region without an identifiable disease. Severity of pain in interstitial cystitis varies greatly and often is accompanied by increased urination frequency and urgency.Urination: Discharge of URINE, liquid waste processed by the KIDNEY, from the body.Administration, Oral: The giving of drugs, chemicals, or other substances by mouth.Propantheline: A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking.Urinary Bladder, Neurogenic: Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.Urodynamics: The mechanical laws of fluid dynamics as they apply to urine transport.Mandelic Acids: Analogs or derivatives of mandelic acid (alpha-hydroxybenzeneacetic acid).Ureter: One of a pair of thick-walled tubes that transports urine from the KIDNEY PELVIS to the URINARY BLADDER.Urinary Bladder, Overactive: Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.Cystotomy: Surgical incision or puncture into a URINARY BLADDER. Cystotomy may be used to remove URINARY CALCULI, or to perform tissue repair and reconstruction.Urothelium: The epithelial lining of the URINARY TRACT.Cystectomy: Used for excision of the urinary bladder.Mycobacterium bovis: The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis.Tuberculosis, Cardiovascular: Pathological conditions of the CARDIOVASCULAR SYSTEM caused by infection of MYCOBACTERIUM TUBERCULOSIS. Tuberculosis involvement may include the HEART; the BLOOD VESSELS; or the PERICARDIUM.Urinary Bladder Neck Obstruction: Blocked urine flow through the bladder neck, the narrow internal urethral opening at the base of the URINARY BLADDER. Narrowing or strictures of the URETHRA can be congenital or acquired. It is often observed in males with enlarged PROSTATE glands.Neoplasm Recurrence, Local: The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.Dose-Response Relationship, Drug: The relationship between the dose of an administered drug and the response of the organism to the drug.Drug Administration Schedule: Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience.Rats, Sprague-Dawley: A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.Ureteral Neoplasms: Cancer or tumors of the URETER which may cause obstruction leading to hydroureter, HYDRONEPHROSIS, and PYELONEPHRITIS. HEMATURIA is a common symptom.Immunotherapy: Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.Antibiotics, Antineoplastic: Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.Tuberculosis, Male Genital: MYCOBACTERIUM infections of the male reproductive tract (GENITALIA, MALE).Reflex, Abnormal: An abnormal response to a stimulus applied to the sensory components of the nervous system. This may take the form of increased, decreased, or absent reflexes.Time Factors: Elements of limited time intervals, contributing to particular results or situations.Carcinoma in Situ: A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.Disease Models, Animal: Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.Urethra: A tube that transports URINE from the URINARY BLADDER to the outside of the body in both the sexes. It also has a reproductive function in the male by providing a passage for SPERM.Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Urologic Surgical Procedures: Surgery performed on the urinary tract or its parts in the male or female. For surgery of the male genitalia, UROLOGIC SURGICAL PROCEDURES, MALE is available.Adjuvants, Immunologic: Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity.Prostatism: Lower urinary tract symptom, such as slow urinary stream, associated with PROSTATIC HYPERPLASIA in older men.Injections, Intravenous: Injections made into a vein for therapeutic or experimental purposes.Antineoplastic Agents: Substances that inhibit or prevent the proliferation of NEOPLASMS.United States Food and Drug Administration: An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.Urination Disorders: Abnormalities in the process of URINE voiding, including bladder control, frequency of URINATION, as well as the volume and composition of URINE.Reflex: An involuntary movement or exercise of function in a part, excited in response to a stimulus applied to the periphery and transmitted to the brain or spinal cord.Rats, Wistar: A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain.Neuromuscular Agents: Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission (NEUROMUSCULAR BLOCKING AGENTS), and drugs that act centrally as skeletal muscle relaxants (MUSCLE RELAXANTS, CENTRAL). Drugs used in the treatment of movement disorders are ANTI-DYSKINESIA AGENTS.Drug Administration Routes: The various ways of administering a drug or other chemical to a site in a patient or animal from where the chemical is absorbed into the blood and delivered to the target tissue.Hyperthermia, Induced: Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs.Botulinum Toxins, Type A: A serotype of botulinum toxins that has specificity for cleavage of SYNAPTOSOMAL-ASSOCIATED PROTEIN 25.Mice, Inbred C57BLPentosan Sulfuric Polyester: A sulfated pentosyl polysaccharide with heparin-like properties.Hypogastric Plexus: A complex network of nerve fibers in the pelvic region. The hypogastric plexus distributes sympathetic fibers from the lumbar paravertebral ganglia and the aortic plexus, parasympathetic fibers from the pelvic nerve, and visceral afferents. The bilateral pelvic plexus is in its lateral extent.AcroleinUrinary Catheterization: Passage of a CATHETER into the URINARY BLADDER or kidney.Urologic Neoplasms: Tumors or cancer of the URINARY TRACT in either the male or the female.Aneurysm, Infected: Aneurysm due to growth of microorganisms in the arterial wall, or infection arising within preexisting arteriosclerotic aneurysms.Dogs: The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)Antimetabolites, Antineoplastic: Antimetabolites that are useful in cancer chemotherapy.Parasympatholytics: Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.Urine: Liquid by-product of excretion produced in the kidneys, temporarily stored in the bladder until discharge through the URETHRA.Administration, Intranasal: Delivery of medications through the nasal mucosa.Capsaicin: An alkylamide found in CAPSICUM that acts at TRPV CATION CHANNELS.Mitomycins: A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.Neurons, Efferent: Neurons which send impulses peripherally to activate muscles or secretory cells.Pressure: A type of stress exerted uniformly in all directions. Its measure is the force exerted per unit area. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)DeoxycytidineUrinary Bladder Calculi: Stones in the URINARY BLADDER; also known as vesical calculi, bladder stones, or cystoliths.Neurons, Afferent: Neurons which conduct NERVE IMPULSES to the CENTRAL NERVOUS SYSTEM.Mucous Membrane: An EPITHELIUM with MUCUS-secreting cells, such as GOBLET CELLS. It forms the lining of many body cavities, such as the DIGESTIVE TRACT, the RESPIRATORY TRACT, and the reproductive tract. Mucosa, rich in blood and lymph vessels, comprises an inner epithelium, a middle layer (lamina propria) of loose CONNECTIVE TISSUE, and an outer layer (muscularis mucosae) of SMOOTH MUSCLE CELLS that separates the mucosa from submucosa.Combined Modality Therapy: The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.Urinary Tract: The duct which coveys URINE from the pelvis of the KIDNEY through the URETERS, BLADDER, and URETHRA.Injections, Intraperitoneal: Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall.Vesico-Ureteral Reflux: Retrograde flow of urine from the URINARY BLADDER into the URETER. This is often due to incompetence of the vesicoureteral valve leading to ascending bacterial infection into the KIDNEY.Mice, Inbred C3HMuscle Contraction: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.Kidney Pelvis: The flattened, funnel-shaped expansion connecting the URETER to the KIDNEY CALICES.Pelvis: The space or compartment surrounded by the pelvic girdle (bony pelvis). It is subdivided into the greater pelvis and LESSER PELVIS. The pelvic girdle is formed by the PELVIC BONES and SACRUM.Rats, Inbred F344Muscarinic Antagonists: Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system.
The association between CD2+ peripheral blood lymphocyte subsets and the relapse of bladder cancer in prophylactically BCG-treated patients. (1/242)
We investigated the potential existence of differences in the distribution of T-lymphocyte subsets and in the proliferative response of these CD2+ cells to polyclonal mitogens in patients with transitional cell bladder carcinoma (SBTCC) treated with prophylactic intracavitary instillations of bacillus Calmette-Guerin (BCG) according to their clinical response to this treatment. Before BCG treatment, different subset distribution (CD8+ and CD3+ CD56+), activation antigen expression (CD3+ HLA- DR+) and proliferative response to mitogenic signals were found in CD2+ cells from SBTCC patients prophylactically treated with BCG who remained free of disease or those who had recurrence of tumour. Otherwise, the prophylactic intracavitary BCG instillations in SBTCC patients are associated with a transitory variation of T-lymphocyte subset distribution (CD4 and CD8) and activation antigens expression (CD25). (+info)Mycobacterium bovis BCG causing vertebral osteomyelitis (Pott's disease) following intravesical BCG therapy. (2/242)
We report a case of Mycobacterium bovis BCG vertebral osteomyelitis in a 79-year-old man 2.5 years after intravesical BCG therapy for bladder cancer. The recovered isolate resembled M. tuberculosis biochemically, but resistance to pyrazinamide (PZA) rendered that diagnosis suspect. High-pressure liquid chromatographic studies confirmed the diagnosis of M. bovis BCG infection. The patient was originally started on a four-drug antituberculous regimen of isoniazid, rifampin, ethambutol, and PZA. When susceptibility studies were reported, the regimen was changed to isoniazid and rifampin for 12 months. Subsequently, the patient was transferred to a skilled nursing facility for 3 months, where he underwent intensive physical therapy. Although extravesical adverse reactions are rare, clinicians and clinical microbiologists need to be aware of the possibility of disseminated infection by M. bovis BCG in the appropriate setting of clinical history, physical examination, and laboratory investigation. (+info)Toxicology and pharmacokinetics of intravesical gemcitabine: a preclinical study in dogs. (3/242)
More active and well-tolerated agents are needed for the treatment of superficial bladder cancer. This study investigated intravesical gemcitabine to establish the toxicology and pharmacokinetics necessary for clinical trials. Beagle dogs (in groups of 2; n = 6) received 100 mg, 350 mg, or 1 g of drug by intravesical administration on alternate days three times/week for 4 weeks. Animals were observed for clinical signs of toxicity; gemcitabine levels and peripheral blood counts were taken three times weekly. The dogs were euthanized, and a full necropsy was performed at days 1 and 14 after the last dose. Intravesical gemcitabine was given at 100 mg (n = 2), 350 mg (equivalent to the 1000 mg/m2 human dose; n = 3), and 3.5 g (n = 1). i.v. gemcitabine was given at 350 mg (n = 2). Plasma samples drawn at time points up to 8 h were analyzed for systemic absorption and clearance of drug. Doses of 100 and 350 mg were well tolerated with no clinical side effects. Necropsies revealed normal bone marrow cellularity and normal bladder histology. At 1 g, signs of severe clinical toxicity were evident, and after only three doses, necropsies demonstrated severe bone marrow hypoplasia, cystitis, and intestinal necrosis. At all intravesical doses, significant systemic absorption was seen. The T1/2 (+/- SD) for intravesical and i.v. administration of 350 mg was 328 (+/-6.8) min and 99.3 (+/-5.2) min, respectively (P<0.001). Intravesical gemcitabine is well tolerated and has no direct bladder toxicity at doses up to 1000 mg/m2. Higher doses result in gastrointestinal, bladder, and bone marrow toxicity. (+info)Role of IL-12 in the induction and potentiation of IFN-gamma in response to bacillus Calmette-Guerin. (4/242)
Although Mycobacterium bovis bacillus Calmette-Guerin (BCG) has been accepted as the most effective agent in clinical use against superficial bladder cancer, its mechanism of action remains incompletely understood. A kinetic analysis in assessing the potential role of cytokines from BCG-stimulated murine splenocytes showed that IL-12 expression preceded that of other cytokines. Experiments subtracting endogenous BCG-driven IL-12 using neutralizing Ab or augmenting its activity with supplemental rIL-12 revealed not only that IL-12 plays a dominant role in IFN-gamma induction but also that it is normally dose limiting. A striking increase in IFN-gamma production could be generated in both mouse and human immunocompetent cell culture by the addition of even a small amount of rIL-12. Moreover, this same synergistic effect could be replicated during in vivo administration of BCG plus rIL-12 into the mouse bladder and was observed in a patient receiving intravesical combination therapy. In costimulation cultures, this synergy appeared to partially rely on IL-18 and IL-2 and could be down-regulated by IL-10. This suggests that a dynamic interplay between Th1 and Th2 cytokines is responsible for net IFN-gamma production. The ability of supplemental exogenous IL-12 to strongly shift this balance toward Th1 provides an immunological basis for using it in conjunction with intravesical BCG for bladder cancer immunotherapy. (+info)Primary lymphoma of the bladder treated successfully with mitozantrone gel. (5/242)
We describe a young man who presented with a short history of painless haematuria. Subsequent investigations and biopsy of lesions found in his bladder at cystoscopy confirmed the diagnosis of primary lymphoma of the bladder. Computed tomography studies confirmed the disease was localised to his bladder. Unfortunately, the tumour was not eradicated by radiotherapy. However, it was successfully treated with intravesical mitozantrone given in a novel gel formation. Three years after diagnosis the patient remains well with no evidence of recurrence. (+info)Targeting superficial bladder cancer by the intravesical administration of copper-67-labeled anti-MUC1 mucin monoclonal antibody C595. (6/242)
PURPOSE: More effective intravesical agents are required to limit the recurrence and progression of superficial bladder cancer. This study assessed the ability of copper-67 ((67)Cu)-C595 murine antimucin monoclonal antibody to bind selectively to superficial bladder tumors when administered intravesically, with a view to its development for therapy. PATIENTS AND METHODS: Approximately 20 MBq of (67)Cu-C595 monoclonal antibody was administered intravesically to 16 patients with a clinical indication of superficial bladder cancer. After 1 hour, the bladder was drained and irrigated. Tissue uptake was assessed by imaging and by the assay of tumor and normal tissues obtained by endoscopic resection. RESULTS: Tumor was correctly identified in the images of 12 of 15 patients who were subsequently found to have tumors. Assay of biopsy samples at 2 hours showed a mean tumor uptake of 59.4% of the injected dose per kilogram (SD = 48.0), with a tumor-to-normal tissue ratio of 14.6:1 (SD = 20). After 24 hours (n = 5), this decreased to 4.3% of the injected dose per kilogram (SD = 2.9), with a tumor-to-normal tissue ratio of 1.8:1 (SD = 0.8). CONCLUSION: This study indicates a promising method for the treatment of superficial bladder cancer. Although the mean initial tumor uptake was high, effective therapy of bladder tumors will require an increased retention of the cytotoxic radionuclide in tumor tissue. (+info)Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model. (7/242)
Using a novel orthotopic MBT-2 murine bladder tumor model, we evaluated the feasibility of intravesical gene therapy utilizing a cationic liposome, DMRIE/DOPE. Superficial bladder tumors were consistently established by intravesical instillation of 5x10(5) MBT-2 cells in syngeneic C3H female mice. In situ gene transfer to bladder tumors was accomplished via intravesical instillation of plasmid DNA/DMRIE/DOPE lipoplex. Beta-Galactosidase (beta-gal) gene expression was preferentially evident in bladder tumors and was present for at least 7 days after a single 30 min in situ transfection. Murine interleukin-2 (IL-2) gene was used for treatment of 3-day-old pre-established bladder tumors. Forty percent of animals treated with IL-2 gene were completely free of tumors by 60 days following the initial tumor implantation, while all control groups treated with beta-gal gene died. Those animals initially cured of pre-established tumors were completely resistant to a subsequent tumor re-challenge and their splenocyte-derived cytotoxic T lymphocytes were shown to be specific to MBT-2 cells, indicating that immunological memory against MBT-2 tumors was elicited by the treatment. These results demonstrate the possibility of an effective clinical application of this in situ intravesical IL-2 gene delivery system to high-risk superficial bladder tumors, obviating a need for tumor procurement and ex vivo gene transfer. (+info)Mechanisms of action of intravesical bacille Calmette-Guerin: local immune mechanisms. (8/242)
The local immune response to mycobacteria is complex, but mycobacterial antigen presentation by phagocytes to T helper cells is the pivotal interaction. Bacille Calmette-Guerin (BCG) vaccination is associated with the development of antituberculosis immunity but not necessarily with antitumor immunity. Animal studies have shown that an intact host immune system is required for the antitumor activity of BCG. Immunosuppressed and, particularly, T cell-depleted individuals fail to respond to BCG immunotherapy. Clinical and laboratory evidence suggest that the antitumor activity is concentrated at the site of BCG administration, which reinforces the view that local immune mechanisms are responsible for this phenomenon. (+info)Intravesical infusion is into the urinary bladder.. *intravitreal, through the eye. *Subcutaneous (under the skin).[22] This ... extra-amniotic administration, between the endometrium and fetal membranes. *nasal administration (through the nose) can be ... Administration through the gastrointestinal tract is sometimes termed enteral or enteric administration (literally meaning ' ... Strictly enteral administration (directly into the intestines) can be used for systemic administration, as well as local ( ...
In 1959, thiotepa was registered with the Food and Drug Administration (FDA) as a drug therapy for several solid cancers. On ... Thiotepa is used as intravesical chemotherapy in bladder cancer. It may be used prophylactically to prevent seeding of tumor ... "Urgent, thioTEPA update" (PDF). Food and Drug Administration. Adienne Pharma & Biotech. 5 April 2011. Retrieved 25 November ... For intravesical use, thiotepa is given in 30 mg doses weekly, for four to six weeks. Efficacy in tumor control may reach 55 ...
Di Stasi SM, Riedl C (June 2009). "Updates in intravesical electromotive drug administration of mitomycin-C for non-muscle ... April 2009). "Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the ... Alfred Witjes J, Hendricksen K, Gofrit O, Risi O, Nativ O (June 2009). "Intravesical hyperthermia and mitomycin-C for carcinoma ... page needed] Witjes JA, Hendricksen K (January 2008). "Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a ...
Intravesical drug administration is the delivery of pharmaceuticals to the urinary bladder through a catheter. This route of ... Consequently, direct administration through the fibrous tunic is common. This is made difficult due to the numerous defense ... With a 0.1-0.7 mm thick mucus layer, the oral cavity serves as an important route of administration for mucoadhesive dosages. ... With an active surface area of 160 cm2, the nasal cavity is another noteworthy route of mucoadhesive administration. Due to the ...
... total parenteral nutrition Intravesical infusion is into the urinary bladder. intravitreal, through the eye Subcutaneous (under ... Strictly enteral administration (directly into the intestines) can be used for systemic administration, as well as local ( ... extra-amniotic administration, between the endometrium and fetal membranes nasal administration (through the nose) can be used ... Parenteral administration generally acts more rapidly than topical or enteral administration, with onset of action often ...
After administration of apaziquone directly into the urinary bladder (intravesically), the drug and its active metabolite were ... October 2006). "Phase I/II pilot study of intravesical apaziquone (EO9) for superficial bladder cancer". J. Urol. 176 (4 Pt 1 ... The U.S. Food and Drug Administration (FDA) has granted Fast Track review status to apaziquone for this indication. "UvA ...
It was originally launched as Valstar in the U.S. in 1999 for intravesical therapy of Bacille Calmette-Guérin (BCG)-refractory ... Food and Drug Administration News. The MQN Weekly Bulletin, Jan. 11, 2008 "Endo Pharmaceuticals launches VALSTAR for treating ...
... , literally "under the lip", from Latin, refers to the pharmacological route of administration by which ... Upper lip administration[edit]. Some drugs are inactive in the digestive tract, but this can be avoided if held between the ... Sublabial administration should not be confused with sublingual administration, which is under the tongue. The frenulum of the ... Retrieved from "https://en.wikipedia.org/w/index.php?title=Sublabial_administration&oldid=735203906" ...
Intravitreal is a route of administration of a drug or other substance, in which the substance[1] is delivered into the eye. ... Intravitreal administration of drugs is used to treat various conditions of the eye. ... Retrieved from "https://en.wikipedia.org/w/index.php?title=Intravitreal_administration&oldid=836379009" ...
... has certain advantages over oral administration. Being more direct, it is often faster,[quantify] and ... Sublingual (abbreviated SL), from the Latin for "under the tongue", refers to the pharmacological route of administration by ... Sublingual Drug Administration at the US National Library of Medicine Medical Subject Headings (MeSH) ... This may be a preferred method to simple oral administration, because MAO is known to oxidize many drugs (especially the ...
... (from Ancient Greek ἐπί, "on, upon" + dura mater) is a medical route of administration in which a drug ... Epidural administration. A freshly inserted lumbar epidural catheter. The site has been prepared with tincture of iodine, and ... This article is about the route of administration and anaesthetic technique. For the anatomical site, see Epidural space. For ... Techniques such as epidural analgesia and epidural anaesthesia employ this route of administration. The epidural route is ...
In certain cancers, administration of hormone agonists, such as progestogens may be therapeutically beneficial. Angiogenesis ... Contemporary methods for generating an immune response against tumours include intravesical BCG immunotherapy for superficial ... Other problems include route of administration, maintenance of stability and activity and targeting at the tumor vasculature. ... Food and Drug Administration. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm533873.htm Agrelo R, Cheng WH, ...
Concurrently the slow administration of intravenous diuretics such as furosemide can correct the sodium by diuresis, however ... The patient should be kept horizontal, as assuming the Trendelenburg position (head tilt down 20°) reduces the intra-vesical ...
"Filling in Wrinkles Safely". U.S. Food and Drug Administration. 2016-12-20. Wickens JM1, Alsaab HO2, Kesharwani P3, Bhise K2, ... Boucher, W. S.; Letourneau, R.; Huang, M.; Kempuraj, D.; Green, M.; Sant, G. R.; Theoharides, T. C. (2002). "Intravesical ... "Soft Tissue Fillers Approved by the Center for Devices and Radiological Health". U.S. Food and Drug Administration. 2015-07-27 ...
In case of oral administration this 'enzymatic barrier' is even more pronounced as an additional degradation caused by ... "Development of pre-activated α-cyclodextrin as a mucoadhesive excipient for intra-vesical drug delivery". Int. J. Pharm. 534 (1 ... Madgulkar, AR; Bhalekar, MR; Kadam, AA (2017). "Improvement of oral bioavailability of lopinavir without co-administration of ... "Biodistribution and pharmacokinetics of EGFR-targeted thiolated gelatin nanoparticles following systemic administration in ...
Its a fully funded Grant-in-Aid Institution of Department of Atomic Energy, which also oversees the administration of institute ... and the role of urinary cytokines in intravesical BCG therapy in superficial bladder cancer. The biology of HIV-2, the virus ...
... intravesical bacillus Calmette Guerin, intravesical resiniferatoxin), high-pressure and long-duration hydrodistention, and ... "Policy Interpretation Ruling Titles II and XVI: Evaluation of Interstitial Cystitis". Social Security Administration. Archived ... Tyagi P, Kashyap MP, Kawamorita N, Yoshizawa T, Chancellor M, Yoshimura N (January 2014). "Intravesical liposome and antisense ...
However, it is important to note an abscess is not always associated with incorrect administration, and it is one of the more ... Houghton, BB; Chalasani, V; Hayne, D; Grimison, P; Brown, CS; Patel, MI; Davis, ID; Stockler, MR (May 2013). "Intravesical ... Nonetheless, the buttock is an alternative site of administration because it provides better cosmetic outcomes. BCG vaccine ... Lamm DL, Blumenstein BA, Crawford ED (1991). "A randomized trial of intravesical doxorubicin and immunotherapy with bacille ...
Grotenhermen F (June 2001). "Harm Reduction Associated with Inhalation and Oral Administration of Cannabis and THC". Journal of ... September 2008). "Effect of intrapulmonary tetrahydrocannabinol administration in humans". Journal of Psychopharmacology. 22 (7 ... for the pulmonary administration of tetrahydrocannabinol". Journal of Pharmaceutical Sciences. 95 (6): 1308-17. doi:10.1002/jps ... Regulated US Food and Drug Administration nicotine replacement products may be safer than e-cigarettes,[31] but e-cigarettes ...
Administration of lipid-based formulations to minipigs in the fasted and fed state". Eur J Pharm Sci. 31 (1): 8-15. PMID ... Within the last years SMEDDS were also utilized for the oral administration of biologics. Due to ion pairing with appropriate ... Gibaud, S. P.; Attivi, D. (2012). "Microemulsions for oral administration and their therapeutic applications". Expert Opinion ... for oral administration containing medium and long chain triglycerides". Eur J Pharm Sci. 28 (3): 233-42. PMID 16650738. doi: ...
A new method of drug administration". Current Researches in Anesthesia and Analgesia. 26 (6): 221-230. PMID 18917536.. ... August 14, 2014: The U.S. Food and Drug Administration (FDA) approved the use of the PharmaJet Stratis 0.5ml Needle-free Jet ... Warren, J; Ziherl, FA; Kish, AW; Ziherl, LA (1955). "Large-scale administration of vaccines by means of an automatic jet ... Needle-free Injector Receives WHO PQS Certification as a Pre-qualified Delivery Device for Vaccine Administration". ...
This would be used when administration by mouth was not possible because of the condition of the patient.[6] The Murphy drip ... Yung-Feng Hung, Automatically closed dripping apparatus for intravenous administration, US patent 5 234 414, filed 28 September ... administration of strong coffee through the rectum via a Murphy drip. When the attack got underway, Miller was joined by his ...
Oxygen helmets are used in hyperbaric oxygen chambers for oxygen administration.[1] They are transparent, lightweight plastic ... Oxygen helmets are often preferred for oxygen administration in hyperbaric oxygen chambers for children and patients that are ... and hyperbaric chamber and other patients who require administration of pure oxygen, such as carbon monoxide poisoning and ...
Many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and ... Compared with other routes of administration, such as oral medications, the intravenous route is the fastest way to deliver ... One reason veins are preferred over arteries for intravascular administration is because the flow will pass through the lungs ... The intravenous route of administration can be used for injections (with a syringe at higher pressures) or infusions (typically ...
Autoinjectors were originally developed for the rapid administration of nerve gas antidotes in kits like the Mark I NAAK. The ... Annex I: List of the names, pharmaceutical form(s), strength(s) of the medicinal product(s), route(s) of administration, ... The intramuscular route is preferred over subcutaneous administration because the latter may have delayed absorption.[3][4] ...
... begins with the contraction of the muscles attached to the rib cage; this causes an expansion in the chest cavity. Then takes place the onset of contraction of the diaphragm, which results in expansion of the intrapleural space and an increase in negative pressure according to Boyle's law. This negative pressure generates airflow because of the pressure difference between the atmosphere and alveolus. Air enters, inflating the lung through either the nose or the mouth into the pharynx (throat) and trachea before entering the alveoli.[citation needed] Other muscles that can be involved in inhalation include:[2] ...
Intravesical administration of drugs directly into the bladder allows a high concentration of medication to reach the target ... Intravesical Treatments: Intravesical drug instillations are second-line options per the AUA guidelines and consist of DMSO, ... Intravesical lidocaine with heparin and/or sodium bicarbonate may be used for those who have acute episodes of severe bladder ... DMSO is the only drug approved by the FDA for intravesical drug instillation.3 It is thought to provide relief by having anti- ...
negative urine pregnancy test on the day of treatment prior to the administration of study medication for females of ... 12 conclusion pregnancy outcomes appear good following treatment for interstitial cystitis with 1 course of intravesical dmso. ...
... Qiong Lu,1 Fen Jiang,2 Ran Xu,3 Xiao-Kun ...
... BJU Int. 2004 Jun; ... Patients and methods: Forty women (mean age 35 years) with a history of recurrent UTI received intravesical instillations of HA ...
Subjects who cannot tolerate intravesical dosing or intravesical surgical manipulation. *Intravesical therapy within 6 weeks of ... Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer. The safety and ... The total dose will be given as a single, one-hour intravesical administration which may, depending on clinical response, be ... The total dose will be given as a single, one-hour intravesical administration which may, depending on clinical response, be ...
1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory ... 1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory ... Phase 1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG ... Subjects who have a complete response to treatment at Week 12 in Part 1 receive second regimen of intravesical administration ...
To evaluate the safety of intravesical administration of a second-generation ultrasound (US) contrast agent for the diagnosis ... Thus, ce-VUS with intravesical administration of the second-generation US contrast agent (SonoVue®) for vesicoureteral reflux ... Contrast-enhanced voiding urosonography with intravesical administration of a second-generation ultrasound contrast agent for ...
Phase II Trial of concurrent administration of intravesical BCG & Interferon in the treatment and prevention of recurrence of ...
Hexaminolevulinate Hydrochloride Intravesical Solution) may treat, uses, dosage, side effects, drug interactions, warnings, ... Cysview (hexaminolevulinate hydrochloride) for Intravesical Solution is intended for intravesical administration only after ... malignant lesions may not fluoresce following Cysview (hexaminolevulinate hydrochloride intravesical solution) administration, ... administration and are removed following the Cysview (hexaminolevulinate hydrochloride intravesical solution) instillation. ...
At all intravesical doses, significant systemic absorption was seen. The T1/2 (±SD) for intravesical and i.v. administration of ... We have demonstrated a markedly prolonged half-life after intravesical administration when compared with i.v. administration. ... Intravesical Administration.. Animals (n = 6) were initially treated with 350 mg (n = 1) and 3.5 g (n = 1) of drug, and blood ... Serum gemcitabine levels after 350 mg (n = 2) of drug by i.v. (♦; X) administration and by intravesical (. , , ▪) ...
This case illustrates the fact that although intravesical administration of bacillus Calmette-Guerin is generally considered to ... diagnosed 5 years after intravesical treatment with bacillus Calmette-Guerin therapy for bladder cancer. An 83-year-old ... two transurethral resections for high-grade transitional cell carcinoma of the bladder and had received 12 intravesical ... Intravesical administration of BCG has proved to be an effective form of treatment for some stages of bladder cancer [4]. There ...
To describe a case of epididymo-orchitis that developed four years after treatment with intravesical bacillus Calmette-Guérin ( ... Administration, Intravesical. Aged. BCG Vaccine / adverse effects*, therapeutic use. Carcinoma, Transitional Cell / ... OBJECTIVE: To describe a case of epididymo-orchitis that developed four years after treatment with intravesical bacillus ...
Intravesical drug administration and urine recovery in mice. Mice were anesthetized by the i.p. administration of ketamine/ ... Induction of elevated serum IFN-γ by intravesical administration of IL-12 plus BCG. Mice were treated intravesically every ... Synergy of intravesical IL-12 with BCG in inducing urinary and serum IFN-γ. The ability of rIL-12 to synergize with BCG to ... Synergy of intravesical IL-12 with BCG in inducing urinary IFN-γ. Mice were treated intravesically every other day with either ...
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.. ...
Thanks to a member here, supporting his father, I decided to try intravesical gentamicin (iGM). I wear a condom style catheter ... Intravesical Administration of Ditropan. By kos20 in forum Care Replies: 5 Last Post: 01-14-2008, 11:23 PM ...
Intravesical infusion is into the urinary bladder.. *intravitreal, through the eye. *Subcutaneous (under the skin).[22] This ... extra-amniotic administration, between the endometrium and fetal membranes. *nasal administration (through the nose) can be ... Administration through the gastrointestinal tract is sometimes termed enteral or enteric administration (literally meaning ... Strictly enteral administration (directly into the intestines) can be used for systemic administration, as well as local ( ...
Cysview (hexaminolevulinate hydrochloride) for Intravesical Solution is intended for intravesical administration only after ... 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dose 2.2 Reconstitution of Cysview 2.3 Bladder Instillation of Cysview 2.4 Use of ... DOSAGE AND ADMINISTRATION Training in blue light cystoscopy with the Karl Storz D-Light C PDD system is essential prior to the ... Systemic absorption following administration of Cysview is expected to be minimal [see Clinical Pharmacology (12.3)]. The lack ...
Botulinum Toxin Type A Therapy: Intravesical Injection or Electromotive Drug Administration. Empty * Print ... To compare the outcomes of intravesical injection of botulinum toxin A (BoNTA) with intravesical electromotive drug ... administration (EMDA) of BoNTA on urinary incontinence secondary to neuropathic detrusor overactivity (NDO) in children with ...
Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent ... Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent ... Objectives: To compare the clinical effectiveness of the intravesical administration of combined hyaluronic acid and ... Interventions: Patients treated with either intravesical administration of HA+CS or standard of care (antimicrobial/ ...
Intravesical Administration: Patients with papillary carcinoma of the bladder are dehydrated for 8 to 12 hours prior to ... Deaths have occurred after intravesical administration, caused by bone-marrow depression from systemically absorbed drug. ... Intravenous Administration: Thiotepa may be given by rapid intravenous administration in doses of 0.3 to 0.4 mg/kg. Doses ... It is supplied as a non-pyrogenic, sterile Iyophilized powder for intravenous, intracavitary or intravesical administration, ...
ACETIC ACID INDUCED BLADDER PAIN RESPONSES IN RATS 24H AFTER INTRAVESICAL ADMINISTRATION. Ratna Ganabathi*, Pradeep Tyagi, ... INTRAVESICAL ELECTROMOTIVE DRUG ADMINISTRATION.... (EXPERIMENTAL STUDY). Tevlin K1, Korsunskaya I 2, Pushkar D2, 1. Moscow ... ELECTROMOTIVE DRUG ADMINISTRATION (EMDA).... OF PENTOSAN POLYSULFATE (PPS) IN THE THERAPY OF INTERSTITIAL CYSTITIS (IC). Loch A ... INTRAVESICAL RESINIFERATOXIN (RTX) IMPROVES.... LOWER URINARY TRACT SYMPTOMS (LUTS) AND URODYNAMIC PARAMETERS IN PATIENTS WITH ...
Intravesical medication. There is some evidence that introducing agents such as oxybutynin and atropine into the bladder will ... However this route of administration requires regular intermittent catheterisation (Fader et al, 2007). ... Fader, M. et al (2007) Intravesical atropine compared to oral oxybutynin for neurogenic detrusor overactivity: a double-blind, ...
Joint Statement on Intravesical Administration of Therapeutic Medication SUNA and the American Urological Association (AUA) ... Read more about Joint Statement on Intravesical Administration of Therapeutic Medication. Consensus Statement on Advanced ... developed a joint Statement of Practice on Intravesical Administration of Therapeutic Medication. The purpose of the statement ... is to define the performance guidelines surrounding the instillation of intravesical cytotoxic, immunotherapeutic, and/or ...
Administration, Intravesical. The instillation or other administration of drugs into the bladder, usually to treat local ... Self Administration. Administration of a drug or chemical by the individual under the direction of a physician. It includes ... Administration, Topical. The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION ... Intravenous administration of the brand formulation of rocuronium bromide, currently used as a muscle relaxant, has been ...
Administration, Intravesical. The instillation or other administration of drugs into the bladder, usually to treat local ... A single intravesical instillation of Lactobacillus rhamnosus GG is safe in children and adults with neuropathic bladder: A ... A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer ... Surgical intervention combined with intravesical instillation of chemotherapeutics to clear residual cancer cells after ...
InstillationsImmunotherapySystemicDoxorubicinBacillus CalmettINTRAVENOUSTumorEpirubicinPentosan polysuInstillation of intravesicalThiotepaSingle intravesicalReceive intravesicalToxicityHexaminolevulinate hydrochlorideParenteral administrationTURBTInterferonUrothelialCystitisSterileTherapy for bladder cancerHydrochlorideBotulinumRecurrentPostoperativeDosesTherapeutic MedicationModalitiesSafety and EfficacyDosageDILUENTInfusionResectionSurgicalRatsSuperficialGemcitabineBone marrowAdverseMouse bladderInvasive bladderLammPharmacologyRoutes of administratContractionChondroitin
- Forty women (mean age 35 years) with a history of recurrent UTI received intravesical instillations of HA (40 mg in 50 mL phosphate-buffered saline) once weekly for 4 weeks then once monthly for 4 months. (nih.gov)
- The total dose will be given as a single, one-hour intravesical administration which may, depending on clinical response, be repeated every 3 months up to a maximum of 4 instillations. (clinicaltrials.gov)
- He had previously undergone two transurethral resections for high-grade transitional cell carcinoma of the bladder and had received 12 intravesical bacillus Calmette-Guerin instillations without any complications. (biomedcentral.com)
- The patient had previously undergone two transurethral resections for high-grade urothelial carcinoma of the bladder, receiving 12 intravesical BCG instillations without any complications. (biomedcentral.com)
- The benefit of intravesical HA+CS therapy improves when the number of instillations is ≥5. (unibocconi.it)
- PURPOSE After transurethral resection, we compared the efficacy and side effects of weekly intravesical instillations of epirubicin, bacillus Calmette-Guerin (BCG), and BCG plus isoniazid during a 6-week interval followed by 3 weekly maintenance instillations at months 3, 6, 12, 18, 24, 30 and 36 in patients with intermediate and high risk Ta, T1 bladder cancer. (semanticscholar.org)
- The type and number of intravesical instillations given depend on numerous factors, including grade, stage, multifocality of the tumor, and tolerability. (biomedcentral.com)
- Once the TURBT resection site is healed (approximately 1 month), Group 1 (NMIBC) subjects will proceed to a 3-month Induction period (6 weekly NanoDoce intravesical instillations, followed by 6 weeks of rest). (clinicaltrials.gov)
- After the Induction period, following confirmation of non-recurrence, Group 1 subjects will proceed to a 3-month Maintenance period (3 weekly NanoDoce intravesical instillations, followed by 9 weeks of rest). (clinicaltrials.gov)
- After NanoDoce direct injection and the initial intravesical instillation, Group 2 subjects will proceed to institutional standard of care and will not receive Induction of Maintenance intravesical instillations. (clinicaltrials.gov)
- Subjects will also receive an initial NanoDoce intravesical instillation at 2.0 or 3.0 mg/mL and additional Induction (6 weekly NanoDoce intravesical instillations, followed by 6 weeks of rest) and Maintenance (3 weekly NanoDoce intravesical instillations, followed by 9 weeks of rest) instillations at 2.0 or 3.0 mg/mL. (clinicaltrials.gov)
- Intravesical chemotherapy and immunotherapy have resulted in a significant reduction in the risk of disease recurrence. (aacrjournals.org)
- The ability of supplemental exogenous IL-12 to strongly shift this balance toward Th1 provides an immunological basis for using it in conjunction with intravesical BCG for bladder cancer immunotherapy. (jimmunol.org)
- A randomized clinical trial of intravesical doxorubicin immunotherapy with Bacille Calmette-Guerin for transitional carcinoma of the bladder. (swog.org)
- For intermediate-risk patients, clinicians should consider administration of a 6 week course of induction intravesical chemotherapy or immunotherapy. (renalandurologynews.com)
- The majority of patients with a new diagnosis of bladder cancer have non-muscle-invasive bladder cancer, which requires adjuvant intravesical chemotherapy and/or immunotherapy. (biomedcentral.com)
- NMIBC requires adjuvant intravesical chemotherapy and/or immunotherapy. (biomedcentral.com)
- We report the case of a 50 year-old female patient known with bladder tumor operated in January 2014 followed by 4 weeks of intravesical BCG immunotherapy, one administration per week. (biomedcentral.com)
- There are two types of intravesical therapy: chemotherapy and immunotherapy. (urologyhealth.org)
- At all intravesical doses, significant systemic absorption was seen. (aacrjournals.org)
- Strictly enteral administration (directly into the intestines) can be used for systemic administration, as well as local (sometimes termed topical ), such as in a contrast enema , whereby contrast media is infused into the intestines for imaging. (wikipedia.org)
- This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. (bioportfolio.com)
- A major focus of his research lab is development of pre-clinical models of urothelial carcinoma to test systemic and intravesical immunotherapies and nano-particular based chemotherapies. (hopkinsmedicine.org)
- We report 6 cases of adverse systemic reactions to the intravesical instillation of doxorubicin hydrochloride for the treatment of recurrent superficial transitional cell carcinoma of the bladder. (uptodate.com)
- The module will help students develop their knowledge and skills in the administration of systemic anticancer therapies. (ncl.ac.uk)
- Myelosuppression is possible if valrubicin is inadvertently administered systemically or if significant systemic exposure occurs following intravesical administration (e.g., in patients with bladder/rupture perforation). (drugbank.ca)
- Regional chemotherapy for bladder neoplasms using continuous intravesical infusion of doxorubicin: impact of concomitant administration of dimethyl sulfoxide on drug absorption and antitumor activity. (wikigenes.org)
- Adverse reactions to the intravesical administration of doxorubicin hydrochloride: report of 6 cases. (uptodate.com)
- Intravesical administration of the cytotoxic drug doxorubicin is a common treatment for superficial carcinoma of the bladder, but it is associated with significant urological adverse effects. (edu.au)
- As a model of intravesical doxorubicin administration in patients, doxorubicin (1 mg/mL) was applied to the luminal surface of porcine bladders for 60 min. (edu.au)
- The application of luminal doxorubicin, under conditions that mimic intravesical administration to patients, affects urothelial/lamina propria function (increased contractile activity and ATP release) and enhances efferent neurotransmission without affecting detrusor smooth muscle. (edu.au)
- These actions would enhance bladder contractile activity and sensory nerve activity and may explain the adverse urological effects observed in patients following intravesical doxorubicin treatment. (edu.au)
- Bacillus Calmette-Guérin (BCG) 3 is the most effective intravesical agent for the treatment of superficial bladder cancer and prophylaxis against recurrent disease ( 1 , 2 , 3 ). (jimmunol.org)
- Epididymo-orchitis following intravesical bacillus Calmette-Guérin therapy. (biomedsearch.com)
- OBJECTIVE: To describe a case of epididymo-orchitis that developed four years after treatment with intravesical bacillus Calmette-Guérin (BCG) and to review the incidence of this adverse effect. (biomedsearch.com)
- In a multicenter, prospectively randomized study we evaluated bacillus Calmette-Guérin alone vs bacillus Calmette-Guérin plus interferon α-2b and megadose vitamins vs recommended daily allowance vitamins during induction and maintenance intravesical therapy in the treatment of nonmuscle invasive bladder cancer. (nih.gov)
- Patients who were bacillus Calmette-Guérin naïve with carcinoma in situ, Ta or T1 urothelial cancer were randomized to receive intravesical bacillus Calmette-Guérin or bacillus Calmette-Guérin plus interferon α-2b. (nih.gov)
- Interferon α-2b added to bacillus Calmette-Guérin induction and maintenance intravesical therapy did not decrease tumor recurrence in bacillus Calmette-Guérin naïve cases, but was associated with increased fever and constitutional symptoms. (nih.gov)
- Kelley DR, Ratliff TL, Catalona WJ, Shapiro A, Lage JM, Bauer WC, Haaff EO, Dresner SM (1985) Intravesical Bacillus Calmette-Guérin therapy for superficial bladder cancer: effect of Bacillus Calmette-Guérin viability on treatment results. (springer.com)
- Managing the adverse events of intravesical bacillus Calmette-Guérin therapy. (semanticscholar.org)
- In a patient with NMIBC, a clinician may use biomarkers to assess response to intravesical bacillus Calmette-Guérin (BCG) and adjudicate equivocal cytology. (renalandurologynews.com)
- Common examples include oral and intravenous administration. (wikipedia.org)
- Needle insertion angles for 4 types of parenteral administration of medication: intramuscular, subcutaneous, intravenous, and intradermal injection. (wikipedia.org)
- It is supplied as a non-pyrogenic, sterile Iyophilized powder for intravenous, intracavitary or intravesical administration, containing 15 mg of thiotepa. (nih.gov)
- Intravenous administration of the brand formulation of rocuronium bromide, currently used as a muscle relaxant, has been associated with vascular pain accompanied by withdrawal movements of the arm an. (bioportfolio.com)
- The primary purpose of this study is to evaluate the time course of muscle relaxation after administration of three different single intravenous bolus doses of rocuronium bromide for intub. (bioportfolio.com)
- The maximum tolerated dose in humans by either intraperitoneal or intravenous administration is 600 mg/m 2 . (drugbank.ca)
- This intravesical ureterocele has a stenotic opening, causing it to balloon (highlighted by intravenous administration of methylene blue in the urine). (pubmedcentralcanada.ca)
- Superficial bladder cancer lends itself to intravesical therapy due to the potential for direct contact between chemotherapeutic drug and tumor. (aacrjournals.org)
- KLH-IA) were determined in the MB-49 intravesical murine bladder tumor model. (curehunter.com)
- 2 Several studies have shown a benefit of immediate intravesical chemotherapy (IVC) after transurethral resection (TUR) in reducing tumor recurrence. (jnccn.org)
- Analysis of differential PDT effect in rat bladder tumor models according to concentrations of intravesical hexyl-aminolevulinate. (semanticscholar.org)
- This is a clinical trial studying the administration of NanoDoce as a direct injection to the bladder wall immediately after tumor resection and as an intravesical instillation. (clinicaltrials.gov)
- All subjects will receive NanoDoce injected into the index tumor resection site on the bladder wall, immediately following transurethral resection of the bladder tumor (TURBT), followed by an initial NanoDoce intravesical instillation. (clinicaltrials.gov)
- Intravesical administration of the chemotherapeutic agent, thiotepa, led to a reduction in size of established tumor foci after 4 d exposure of drug. (aacrjournals.org)
- Intravesical instillation of epirubicin, bacillus Calmette-Guerin and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder: a European Organization for Research and Treatment of Cancer genito-urinary group randomized phase III trial. (semanticscholar.org)
- For patients with known or suspected low- or intermediate-risk tumors, clinicians should consider administering a single postoperative instillation of intravesical chemotherapy, such as mitomycin C or epirubicin, within 24 hours of TUR. (renalandurologynews.com)
- Oral pentosan polysulfate sodium (PPS) and intravesical dimethylsulfoxide (DMSO) are the only FDA-approved agents. (arhp.org)
- The purpose of the statement is to define the performance guidelines surrounding the instillation of intravesical cytotoxic, immunotherapeutic, and/or therapeutic drugs via sterile technique catheterization for patients with non-muscle invasive bladder cancer (urothelial carcinoma) or interstitial cystitis/bladder pain syndrome. (suna.org)
- In 1959, thiotepa was registered with the Food and Drug Administration (FDA) as a drug therapy for several solid cancers. (wikipedia.org)
- Thiotepa is used as intravesical chemotherapy in bladder cancer. (wikipedia.org)
- For intravesical use, thiotepa is given in 30 mg doses weekly, for four to six weeks. (wikipedia.org)
- Early onset life-threatening myelosuppression after low dose of intravesical thiotepa" (pdf). (wikipedia.org)
- Pregnancy: The administration of thiotepa to pregnant women is not recommended except in cases where the benefit to be gained outweighs the risk of teratogenicity involved. (rxmed.com)
- There have been rare reports of chemical cystitis or hemorrhagic cystitis following intravesical, but not parenteral administration of thiotepa. (cancermonthly.com)
- A single intravesical instillation of Lactobacillus rhamnosus GG is safe in children and adults with neuropathic bladder: A phase Ia clinical trial. (bioportfolio.com)
- More than 60% of patients who receive intravesical BCG will convert to a positive PPD skin test. (bladdercancersupport.org)
- Intravesical gemcitabine is well tolerated and has no direct bladder toxicity at doses up to 1000 mg/m 2 . (aacrjournals.org)
- Local toxicity patterns associated with intravesical bacillus calmette-guerin. (swog.org)
- Total drug administration is usually limited by considerations of drug toxicity, e.g. myelosuppression which can be both debilitating and life-threatening. (uthsc.edu)
- Cysview (hexaminolevulinate hydrochloride) for Intravesical Solution is intended for intravesical administration only after reconstitution with the supplied 50 mL DILUENT. (rxlist.com)
- Cysview (hexaminolevulinate hydrochloride) for Intravesical Solution and DILUENT for Cysview are supplied together as a kit. (rxlist.com)
- Cysview (hexaminolevulinate hydrochloride) for Intravesical Solution is supplied as a sterile, non-pyrogenic, freeze-dried, white to off-white or pale yellow, powder containing 100 mg of hexaminolevulinate hydrochloride (equivalent of 85 mg of hexaminolevulinate) in a 10 mL clear glass vials. (rxlist.com)
- The DILUENT for Cysview (hexaminolevulinate hydrochloride intravesical solution) is a sterile, non-pyrogenic solution (pH 6) containing 0.61 mg/ mL disodium hydrogen phosphate, 0.58 mg/mL of potassium dihydrogen phosphate, 7.02 mg/mL of sodium chloride, hydrochloric acid, sodium hydroxide, and water for injection. (rxlist.com)
- The reconstituted solution of Cysview (hexaminolevulinate hydrochloride intravesical solution) contains 2 mg/ml of hexaminolevulinate hydrochloride and is colorless to pale yellow. (rxlist.com)
- Cysview (hexaminolevulinate hydrochloride intravesical solution) is indicated for use in the cystoscopic detection of non-muscle invasive papillary cancer of the bladder among patients suspected or known to have lesion(s) on the basis of a prior cystoscopy. (rxlist.com)
- Cysview (hexaminolevulinate hydrochloride intravesical solution) is used with the Karl Storz D-Light C Photodynamic Diagnostic (PDD) system to perform cystoscopy with the blue light setting (Mode 2) as an adjunct to the white light setting (Mode 1). (rxlist.com)
- The recommended dose for adults is 50 mL of reconstituted solution of Cysview (hexaminolevulinate hydrochloride intravesical solution) (2.2), instilled into the bladder via a urinary catheter (2.3). (rxlist.com)
- Cysview (hexaminolevulinate hydrochloride intravesical solution) is supplied as a kit containing two vials: a clear glass vial labeled as Cysview (hexaminolevulinate hydrochloride) for Intravesical Solution, containing 100 mg hexaminolevulinate hydrochloride as a powder, and a vial labeled as DILUENT for Cysview (hexaminolevulinate hydrochloride intravesical solution) , containing 50 mL of the diluent in a polypropylene vial. (rxlist.com)
- 2. Penetrate the stopper of the Cysview (hexaminolevulinate hydrochloride intravesical solution) powder vial with the needle and inject 10 mL of the diluent from the syringe into the powder vial (Figure 2). (rxlist.com)
- Parenteral administration can be performed by injection , that is, using a needle (usually a hypodermic needle ) and a syringe , or by the insertion of an indwelling catheter . (wikipedia.org)
- Theoretically, parenteral administration of oxybutynin should avoid first-pass metabolism in the liver and may therefore be associated with less side-effects. (nursinginpractice.com)
- For many patients, treatment consists of TURBT in combination with intravesical therapy to lower the risk the cancer will return. (urologyhealth.org)
- Clinical trials of intravesical alpha-2 interferon for carcinoma in-situ are also in progress. (springer.com)
- The guidelines strongly recommend administration of a 6-week induction course of BCG to high-risk patients with newly diagnosed carcinoma in situ , high-grade T1, or high-risk Ta urothelial carcinoma. (renalandurologynews.com)
- Enhanced urothelial ATP release and contraction following intravesical" by Stanley Kang, Catherine M. McDermott et al. (edu.au)
- Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome. (painful-bladder.org)
- Intravesical glycosaminoglycan replenishment with chondroitin sulphate in chronic forms of cystitis. (painful-bladder.org)
- MCNA was developed to be delivered as a sterile suspension for intravesical administration by urologists and urology nurses, following the same dosing paradigm as first-line BCG therapy, with the advantage that it can be prepared, handled and disposed of easily and safely. (prnewswire.com)
- To the best of our knowledge, we report the first case of disseminated bacillus Calmette-Guerin infection causing multiple abscesses affecting the pancreatic head and right psoas muscle, diagnosed 5 years after intravesical treatment with bacillus Calmette-Guerin therapy for bladder cancer. (biomedcentral.com)
- Intramuscular administration of drotaverine hydrochloride decreased the time to spontaneous micturition and decreased the incidence of urinary bladder catheterization in male patients who underwent orthopedic surgery under spinal anesthesia. (hindawi.com)
- Modalities such as intravesical Botulinum toxin, neuromodulation (peripheral or sacral) may be offered. (minervamedica.it)
- Objectives: To compare the clinical effectiveness of the intravesical administration of combined hyaluronic acid and chondroitin sulfate (HA+CS) versus current standard management in adult women with recurrent urinary tract infections (RUTIs). (unibocconi.it)
- Intravesical adriamycin for recurrent superficial bladder cancer: A Southwest Oncology Group study. (swog.org)
- Postoperative intravesical chemotherapy is recommended for patients with low- and intermediate-risk NMIBC. (urologyhealth.org)
- The most common types of postoperative intravesical chemotherapy used to treat NMIBC are gemcitabine and mitomycin C, Dr. Ristau says. (urologyhealth.org)
- Recent data shows that a neuromuscular block (NMB) induced by administration of high doses of rocuronium improves surgical conditions in certain procedures. (bioportfolio.com)
- SUNA and the American Urological Association (AUA) developed a joint Statement of Practice on Intravesical Administration of Therapeutic Medication. (suna.org)
- Modalities, ways of administration and indications of these treatments will be presented and discussed. (urofrance.org)
- 2008;179:177-85 - randomized double-blind placebo-controlled study - demonstrated safety and efficacy of combined intravesical and oral PPS for moderate and severe IC. (painful-bladder.org)
- Route of administration and dosage form are aspects of drug delivery . (wikipedia.org)
- A suppository is a solid dosage form that fits for rectal administration . (wikipedia.org)
- Administration of a soluble dosage form by placement under the tongue. (bioportfolio.com)
- However, the mechanism of action of BCG has not yet been defined, nor has the optimal dosage schedule and route of administration been determined. (springer.com)
- Can be administered alone via any injectable route defined by the TGA, or can be administered acting as diluent for an injectable requiring reconstitution prior to administration. (pbs.gov.au)
- This form of bladder cancer is treated predominantly by urologists using surgical resection and intravesical infusion therapy. (newswire.ca)
- Superficial bladder cancer is treated by transuretral resection and in some cases by intravesical chemotherapy. (urofrance.org)
- Recent developments in post-resection intravesical regimens are discussed. (biomedcentral.com)
- Surgical intervention combined with intravesical instillation of chemotherapeutics to clear residual cancer cells after operation is the current standard treatment method for bladder cancer. (bioportfolio.com)
- The guidelines, developed by the American Urological Association (AUA) and the Society for Urologic Oncology (SUO), make 38 recommendations regarding diagnosis, risk stratification, surgical intervention, and intravesical therapy. (renalandurologynews.com)
- This study was developed to determine whether the generation of free radicals, induced by ischemia followed by reperfusion in a model of chronic intravesical obstruction in rats, would lead to damage in the detrusor. (scielo.br)
- Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses. (semanticscholar.org)
- This clinical agent is used to treat superficial carcinoma of the bladder, by direct intravesical instillation. (uthsc.edu)
- Intravesical administration of bacillus Calmette-Guerin, a live attenuated strain of Mycobacterium bovis , is an adjunctive therapy for superficial bladder cancer. (biomedcentral.com)
- This study investigated intravesical gemcitabine to establish the toxicology and pharmacokinetics necessary for clinical trials. (aacrjournals.org)
- Death has occurred after intravesical administration, caused by bone-marrow depression from systematically absorbed drug. (nih.gov)
- Death has occurred after intravesical administration, caused by bone-marrow depression from systemically absorbed drug. (rxmed.com)
- Because of their involvement in the transport, handling, preparation, administration, or disposal of hazardous medications, health care workers across multiple settings are at risk for adverse health consequences from exposure to these drugs. (nursingcenter.com)
- Moreover, this same synergistic effect could be replicated during in vivo administration of BCG plus rIL-12 into the mouse bladder and was observed in a patient receiving intravesical combination therapy. (jimmunol.org)
- Molecular networks discriminating mouse bladder responses to intravesical bacillus Calmette-Guerin (BCG), LPS, and TNF-alpha. (ica-ev.de)
- Endo holds exclusive global rights to develop and market Bioniche's patented formulation of Mycobacterial Cell Wall-DNA Complex (MCC), Urocidin ™ , being developed for the intravesical treatment of non-muscle invasive bladder cancer. (newswire.ca)
- PS, I think it interesting that Dr. Lamm sometimes administers PPD along with intravesical treatments. (bladdercancersupport.org)
- A route of administration in pharmacology and toxicology is the path by which a drug , fluid, poison, or other substance is taken into the body. (wikipedia.org)
- Routes of administration are generally classified by the location at which the substance is applied. (wikipedia.org)
- Routes of administration are usually classified by application location (or exposition). (wikipedia.org)
- Exceptions include the transdermal or transmucosal routes, which are still commonly referred to as routes of administration . (wikipedia.org)
- Includes all routes of administration for implants as defined by the TGA. (pbs.gov.au)
- Includes all injectable routes of administration as defined by the TGA. (pbs.gov.au)
- The introduction of bladder selective antimuscarinic agents, extended release formulations, alternative routes of administration or use of other drugs could be explored. (minervamedica.it)
- Muscarinic drugs increase intravesical pressure, leading to hyperactive detrusor contraction. (hindawi.com)
- Many different products containing chondroitin sulfate and sodium hyaluronate have been reviewed by the U.S. Food and Drug Administration (FDA) for use during cataract surgery. (medlineplus.gov)